S&P 500

5.321,41

0,25%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Chiasma Inc (CHMA)
Chiasma Inc (CHMA) Notícias

CHMA

Chiasma (CHMA)

Chiasma Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CHMA

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
15/02/2022	08:30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CHMA	Chiasma Inc
12/08/2021	07:07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CHMA	Chiasma Inc
09/08/2021	18:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CHMA	Chiasma Inc
06/08/2021	16:18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CHMA	Chiasma Inc
05/08/2021	17:04	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CHMA	Chiasma Inc
27/07/2021	11:00	PR Newswire (US)	Pulmatrix appoints Director Anand Varadan	NASDAQ:CHMA	Chiasma Inc
22/07/2021	17:47	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CHMA	Chiasma Inc
02/07/2021	17:36	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CHMA	Chiasma Inc
02/07/2021	08:28	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:CHMA	Chiasma Inc
24/06/2021	17:30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CHMA	Chiasma Inc
22/06/2021	17:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CHMA	Chiasma Inc
14/05/2021	17:32	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CHMA	Chiasma Inc
06/05/2021	07:51	TipRanks	Chiasma To Merge With Amryt	NASDAQ:CHMA	Chiasma Inc
05/05/2021	18:36	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc.	NASDAQ:CHMA	Chiasma Inc
05/05/2021	08:47	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CHMA	Chiasma Inc
04/03/2021	18:39	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CHMA	Chiasma Inc
04/03/2021	18:24	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CHMA	Chiasma Inc
12/02/2021	18:19	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:CHMA	Chiasma Inc
02/07/2020	15:14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CHMA	Chiasma Inc
01/07/2020	10:05	GlobeNewswire Inc.	Chiasma Announces Pricing of a Public Offering of $70 Million of Common Stock and Pre-Funded Warrants	NASDAQ:CHMA	Chiasma Inc
30/06/2020	17:30	GlobeNewswire Inc.	Chiasma Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:CHMA	Chiasma Inc
26/06/2020	14:28	GlobeNewswire Inc.	Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog	NASDAQ:CHMA	Chiasma Inc
07/05/2020	17:05	GlobeNewswire Inc.	Chiasma Reports First Quarter 2020 Financial Results	NASDAQ:CHMA	Chiasma Inc
30/04/2020	17:01	GlobeNewswire Inc.	Chiasma To Report First Quarter Financial Results On May 7, 2020	NASDAQ:CHMA	Chiasma Inc
28/04/2020	17:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CHMA	Chiasma Inc
22/04/2020	17:45	GlobeNewswire Inc.	Chiasma Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:CHMA	Chiasma Inc
08/04/2020	08:00	GlobeNewswire Inc.	Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners	NASDAQ:CHMA	Chiasma Inc
16/03/2020	17:05	GlobeNewswire Inc.	Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results	NASDAQ:CHMA	Chiasma Inc
09/03/2020	17:05	GlobeNewswire Inc.	Chiasma To Report Fourth Quarter and Full Year 2019 Financial Results On March 16, 2020	NASDAQ:CHMA	Chiasma Inc
13/01/2020	09:00	GlobeNewswire Inc.	Chiasma Announces FDA Acceptance of MYCAPSSA® New Drug Application Resubmission	NASDAQ:CHMA	Chiasma Inc